

Most Read This Week
- Safety and Efficacy of Bimekizumab in Patients With Active Psoriatic Arthritis and Previous Inadequate Response or Intolerance to TNF-α Inhibitors
- Impact of a Multidisciplinary Lifestyle Program on Disease Activity in Patients With Rheumatoid Arthritis
- Rituximab vs Cyclophosphamide Induction Therapy for Patients With Granulomatosis With Polyangiitis
- Association of GERD Symptoms and Esophageal Dilation With the Progression of Systemic Sclerosis–Related ILD
- Benefits and Risks of Physical Activity in Patients With Systemic Lupus Erythematosus
Recently Updated
- Benefits and Risks of Physical Activity in Patients With Systemic Lupus Erythematosus
- Impact of a Multidisciplinary Lifestyle Program on Disease Activity in Patients With Rheumatoid Arthritis
- Long-Term Effectiveness and Persistence of Using Ustekinumab vs TNF Inhibitors in Patients With Psoriatic Arthritis
- Selective Inhibition of the MK2 Pathway in Patients With Rheumatoid Arthritis
- Multi-Biomarker Disease Activity Score as an Objective Tool for Monitoring Rheumatoid Arthritis